Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy. Till, J. E., Abdalla, A., Bhagwat, N., Black, T. A., Wang, Z., Yee, S. S., Gherardini, P., Kitch, L. J., Selinsky, C., Lyman, J., LaVallee, T., Fisher, G. A., Rahma, O. E., Ko, A. H., Wainberg, Z. A., Wolff, R. A., O'Reilly, E., Vonderheide, R. H., O'Hara, M. H., Carpenter, E. L. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.4122

View details for Web of Science ID 000708120602222